Healthcare
Singapore approves Pfizer's oral med Paxlovid for COVID treatment
Paxlovid is the first oral tablet in the country approved for the treatment of COVID-19.
Singapore approves Pfizer's oral med Paxlovid for COVID treatment
Paxlovid is the first oral tablet in the country approved for the treatment of COVID-19.
US CDC updates travel warning against SG, PH
The warning has risen to 'Level Four: Very High.'
1 in 3 elderly unprepared for living with endemic COVID-19
An SMU study suggests that unpreparedness is linked with government trust.
Social distancing measures to see 14-day extension
The period covered will be from January 21 - February 20, 2022.
Econ Healthcare’s investment policy to undergo review
This comes after the company booked a loss of $3.4m from its Crosstec exit.
68% of women will still report to work despite period pain: survey
Amongst the reasons behind this is period shaming.
Econ Healthcare to book $3.4m loss in Crosstec exit
The loss will not have any material impact on the company.
Stay Home Notice not yet essential for travelers - Iswaran
The focus will be on enhancing tests and limiting VTL arrivals.
SG to provide US CDC with data after ‘unknown’ COVID level classification
MOH clarified the government knows Singapore’s COVID situation “very well.”
MOH sets expiry date for ‘fully vaccinated’ status to 270 days
The policy will take effect on 14 February.
OUE Lippo appoints new COO
Joelle Lee Siew Hong will be responsible for the overall operations of the company.
STGT pushes Vietnam presence with new office
Its expansion will oversee the distribution of the group’s products in Vietnam.
Japanese firms embrace technological advancements to make positive impact
Azbil Corporation strengthens businesses in the Asia Pacific with a focus on the UN's SDGs; whilst Kyowa Kirin's cutting-edge science raises health...
MOH grants Acumen Diagnostics offsite PCR testing license
The testing services will be rolled out through Q&M Dental Group.
SG acquires AstraZeneca's Evusheld
Evusheld is a long-acting antibody candidate for COVID-19 treatment.
OUE Lippo Healthcare Limited divests 100% interests in Japan nursing homes for $163.5m
Perpetual (Asia) Limited is on the other end of the agreement, as the purchaser.
Hilleman Laboratories invests $80m in vaccine development hub
The new facility is the first of its kind in Singapore.
Read Here
Advertise
Sign Up
